Sirolimus: its discovery, biological properties, and mechanism of action
Top Cited Papers
- 6 May 2003
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (3) , S7-S14
- https://doi.org/10.1016/s0041-1345(03)00211-2
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- EFFECTS OF THE PHARMACOKINETIC INTERACTION BETWEEN ORALLY ADMINISTERED SIROLIMUS AND CYCLOSPORINE ON THE SYNERGISTIC PROLONGATION OF HEART ALLOGRAFT SURVIVAL IN RATS1Transplantation, 1996
- A Putative Sirolimus (Rapamycin) Effector ProteinBiochemical and Biophysical Research Communications, 1994
- Inhibition of Human B Lymphocyte Cell Cycle Progression and Differentiation by RapamycinCellular Immunology, 1994
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- Renal effects of rapamycin in the spontaneously hypertensive ratTransplant International, 1994
- Rapamycin: A novel immunosuppressive macrolideMedicinal Research Reviews, 1994
- The effect of rapamycin on renal function in the rat: a comparative study with cyclosporineToxicology Letters, 1991
- FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytesCellular Immunology, 1991
- Incorporation of Acetate, Propionate, and Methionine into Rapamycin by Streptomyces hygroscopicusJournal of Natural Products, 1991
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975